-
Forward Look
Be Alert to Heart HealthRisk of stroke and heart disease increases after a cancer diagnosis.
by Robin Meadows
-
Forward Look
FDA Approves First Biosimilar Cancer TherapyNew product expected to be less expensive.
by Christina Bennett
-
Forward Look
Tracking Treatment Side Effects Benefits Cancer PatientsQuick response to symptoms improves quality of life and survival.
by Cameron Walker
-
Forward Look
Routine Health Care for Cancer SurvivorsPatients are sometimes unsure when to see their primary care provider.
by Dara Chadwick
-
Your Cancer Guide
Talking With Your Children About DyingPrepare to be open with children when cancer treatment has stopped working.
by Hester Hill Schnipper
-
Caregiving With Confidence
The Dangers of Caring Too MuchShifting some responsibilities may empower your loved one and strengthen your relationship.
by Aimee Swartz
-
Breaking Down a Cancer DiagnosisDuring her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
by Marci A. Landsmann
-
-
Your Cancer Guide
Clinical Trial ConsiderationsLearn what questions to ask before participating in a study.
by Hester Hill Schnipper
-
Caregiving With Confidence
Ways to Get OrganizedDevelop a system to avoid being overwhelmed by health care bills and information.
by Aimee Swartz
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
